These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5389145)

  • 61. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The synthesis and pharmacological properties of deamino-4-decarboxamido-oxytocin (1-beta-mercaptopropionic acid-1-alpha-aminobutyric acid-oxytocin).
    Branda LA; Drabarek S; Du Vigneaud V
    J Biol Chem; 1966 Jun; 241(11):2572-5. PubMed ID: 5950415
    [No Abstract]   [Full Text] [Related]  

  • 63. Deuterated oxytocins: the synthesis and biological properties of a crystalline analog of deamino-oxytocin deuterated in the 5-asparagine position.
    Blomquist AT; Rich DH; Carlson BA; Allen GA; Hruby VJ; Takashima H; Nangeroni LL; Glose P; Du Vigneaud V
    Proc Natl Acad Sci U S A; 1969 Sep; 64(1):263-6. PubMed ID: 5263009
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin.
    Bodanszky M; Tolle JC; Seto J; Sawyer WH
    J Med Chem; 1980 Nov; 23(11):1259-61. PubMed ID: 7452679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxytocin analogs with basic amino acid residues in positions 4 and 5. Synthesis and pharmacological properties of [4-ornithine]- and [5-ornithine]-oxytocin.
    Havran RT; Schwartz IL; Walter R
    J Am Chem Soc; 1969 Mar; 91(7):1836-40. PubMed ID: 5779832
    [No Abstract]   [Full Text] [Related]  

  • 66. Natriuretic, diuretic and anti-arginine-vasopressin (ADH) effects of two analogs of oxytocin: [4-leucine]-oxytocin and [2,4-diisoleucine]-oxytocin.
    Chan WY; Du Vigneaud V
    J Pharmacol Exp Ther; 1970 Sep; 174(3):541-9. PubMed ID: 5456186
    [No Abstract]   [Full Text] [Related]  

  • 67. N-acetyl-2-O-methyl-tyrosine-oxytocin: a specific antagonist of oxytocin.
    Krejcí I; Kupková B; Barth T; Jost K
    Physiol Bohemoslov; 1973; 22(3):315-22. PubMed ID: 4359811
    [No Abstract]   [Full Text] [Related]  

  • 68. Vasopressin analogues with selective pressor activity.
    Berde B; Boissonnas RA; Huguenin RL; Stürmer E
    Experientia; 1964 Jan; 20(1):42-3. PubMed ID: 5892275
    [No Abstract]   [Full Text] [Related]  

  • 69. Some pharmacological properties of oxytocin-dimers ( + ).
    Berde B; Jaquenoud PA; Stürmer E
    Experientia; 1971; 27(11):1304-5. PubMed ID: 5134287
    [No Abstract]   [Full Text] [Related]  

  • 70. Synthesis and some pharmacological properties of 8-epsilon-hydroxynorleucine-vasopressin.
    Dreyfuss P
    J Med Chem; 1974 Feb; 17(2):252-5. PubMed ID: 4809261
    [No Abstract]   [Full Text] [Related]  

  • 71. Prolonged action of deamino-carba analogues of oxytocin on the rat uterus in vivo.
    Barth T; Krejcí I; Vanĕcková J; Jost K; Rychlík I
    Eur J Pharmacol; 1974 Jan; 25(1):67-70. PubMed ID: 4435013
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacological and chromatographic studies of the neurohypophysial activities of the pituitary of further elasmobranch species.
    Perks AM
    Gen Comp Endocrinol; 1966 Jun; 6(3):428-42. PubMed ID: 6007028
    [No Abstract]   [Full Text] [Related]  

  • 73. Some pharmacological actions of four synthetic analogues of oxytocin.
    BERDE B; DOEPFNER W; KONZETT H
    Br J Pharmacol Chemother; 1957 Jun; 12(2):209-14. PubMed ID: 13446374
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Solid phase synthesis of (1-deamino,4-valine)-8-D-arginine-vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects.
    Manning M; Balaspiri L; Acosta M; Sawyer WH
    J Med Chem; 1973 Sep; 16(9):975-8. PubMed ID: 4745513
    [No Abstract]   [Full Text] [Related]  

  • 76. Synthesis and some pharmacological properties of 8-L-homoarginine-vasopressin and of 1-deamino-8-L-homoarginine-vasopressin.
    Lindeberg G; Bodanszky M; Acosta M; Sawyer WH
    J Med Chem; 1974 Jul; 17(7):781-3. PubMed ID: 4836417
    [No Abstract]   [Full Text] [Related]  

  • 77. A new approach to the inhibition of puerperal lactation.
    Rolland R; Schellekens L
    J Obstet Gynaecol Br Commonw; 1973 Nov; 80(11):945-51. PubMed ID: 4800555
    [No Abstract]   [Full Text] [Related]  

  • 78. The synthesis of deamino-oxytocin by the solid phase method.
    Takashima H; Du Vigneaud V; Merrifield RB
    J Am Chem Soc; 1968 Feb; 90(5):1323-5. PubMed ID: 5636536
    [No Abstract]   [Full Text] [Related]  

  • 79. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and pharmacological activity of 4-d-glutamine-oxytocin, 5-d-asparagine-oxytocin, and 4-d-glutamine-5-d-asparagine-oxytocin.
    Dutta AS; Anand N; Kar K
    J Med Chem; 1966 Jul; 9(4):497-9. PubMed ID: 5968013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.